• Tioconazole Workflows for Antifungal Research

  2026-09-03

  Build reproducible Tioconazole concentration-response studies, ergosterol-focused assays, and fungal infection models with practical controls for solubility, vehicle effects, and exposure time. The workflow also shows how a recent AML DNA-repair study can inform assay design without implying that Tioconazole acts on the ATG4B pathway.

• Praeruptorin A, DMT1, and Ferroptosis in DIC

  2026-09-03

  A 2025 European Journal of Medicinal Chemistry study used ferrous-ion screening to identify Praeruptorin A as a candidate suppressor of DMT1-linked ferroptosis in doxorubicin-induced cardiomyopathy. The work connects an Fe²⁺-centered discovery assay with cellular, animal, and tumor-combination models, while also defining important limits for translating the findings beyond preclinical cardiotoxicity research.

• DMH1: A Translational Lever for ALK2 Biology

  2026-09-02

  DMH1 offers translational researchers a selective ALK2 inhibitor for connecting BMP-driven cell-state control with organoid engineering and non-small cell lung cancer research. This article outlines the mechanism, validation strategy, protocol considerations, competitive advantages, and limits of using DMH-1 to interrogate BMP signaling without confusing pathway modulation with clinical evidence.

• PDT and STING Activation Suppress Tumor Recurrence

  2026-09-02

  The 2024 ACS Applied Materials & Interfaces study developed GM@P, a nanoparticle combining MHI148-targeted photodynamic therapy with the STING agonist 2′3′-cGAMP. The platform linked tumor-cell ablation, immunogenic cell death, type I interferon induction, dendritic-cell maturation, and CD8+ T-cell infiltration to inhibit breast cancer growth, metastasis, and recurrence in preclinical models.

• Ionizing Radiation Rewires Neural Differentiation Signaling

  2026-09-01

  The reference study shows that ionizing radiation can drive atypical neuronal differentiation in C17.2 mouse neural stem-like cells rather than simply reducing neural stem-cell survival. Its experiments connect this phenotype to PI3K-dependent p53 and STAT3–mGluR1 signaling, providing a mechanistic framework for radiation-associated changes in neuronal function.

• Small Molecules Improve Pancreatic Ductal Organoids

  2026-09-01

  Liao and colleagues developed a small-molecule-based protocol that improves the initiation and long-term expansion of pancreatic ductal organoids while retaining heterogeneous ductal and acinar populations. The resulting model offers a more scalable platform for studying pancreatic exocrine biology, cellular plasticity, disease mechanisms, and future drug-screening workflows.

• Baicalin Restores Adult Visual Plasticity in Amblyopia

  2026-08-31

  A 2026 NeuroImage study found that baicalin reactivated ocular dominance plasticity in adult amblyopic mice, with the strongest response at 10 mg/kg and recovery of visual acuity after reverse suturing. Imaging, electrophysiology, and inhibition-related assays linked this effect to reduced GABAergic constraints in primary visual cortex, while also highlighting important limits for translation to human therapy.

• Prednisolone in ERAD-Linked Immune Assays

  2026-08-31

  Prednisolone provides a controlled synthetic glucocorticoid perturbation for receptor signaling, inflammation modulation, and cellular response studies. This workflow also shows how to compare those effects with ERAD-engaging degradation without conflating Prednisolone with the desonide-based ERADEC chemistry reported for transmembrane proteins.

• Super-Enhancer–SMAD3 Circuit in Early LUAD

  2026-08-30

  Zhang et al. identified LINC01977 as a super-enhancer-hijacked long noncoding RNA that promotes early-stage lung adenocarcinoma through a self-reinforcing canonical TGF-β/SMAD3 circuit. The study links tumor-associated macrophage signaling, enhancer architecture, SMAD3 nuclear activity, and ZEB1 regulation, providing a mechanistic framework for studying early metastatic risk.

• LDN-193189: ALK Inhibitor Workflow Guide

  2026-08-29

  Learn how to use LDN-193189 as a BMP-focused ALK inhibitor for pathway mapping, epithelial barrier assays, and stem-cell plasticity studies. This workflow distinguishes BMP Smad1/5/8 signaling from TGF-β Smad2/3 biology while providing practical dosing, controls, and troubleshooting guidance.

• Fingolimod (FTY720): Reliable Assay Workflows

  2026-08-28

  This scenario-based guide explains how Fingolimod (FTY720), SKU A8548, can support reproducible viability, proliferation, and immune-modulation experiments. It connects receptor pharmacology, dose selection, formulation, storage, and interpretation while distinguishing documented product data from workflow recommendations.

• Praeruptorin A: Applied Research Workflows

  2026-08-28

  Praeruptorin A is an angular pyranocoumarin compound suited to integrated inflammation, ferroptosis, cardiac injury, barrier, and cancer-migration studies. This workflow-focused guide shows how to convert its multi-target profile into controlled cell assays, dose-response experiments, and troubleshooting decisions.

• Thiazovivin (A5506): ROCK Inhibitor Guide

  2026-08-27

  Thiazovivin is a ROCK inhibitor used to address poor post-dissociation survival of human embryonic stem cells and low efficiency during fibroblast-to-induced pluripotent stem cell generation. This guide explains dossier-supported handling and workflow controls, while emphasizing that dosing, exposure time, and clinical use require independent validation.

• (5Z)-7-Oxozeaenol: TAK1 Inhibitor Workflows

  2026-08-27

  Use (5Z)-7-Oxozeaenol to resolve TAK1-dependent inflammatory signaling, from IL-1-triggered NF-κB and JNK/p38 responses to metabolic-stress adaptation. Its selectivity and irreversible action support pathway-ordering, washout, and translational inflammation experiments when paired with disciplined controls.

• Fenipentol: From Natural Product to Assay Design

  2026-08-26

  Fenipentol, also known as 1-Phenyl-1-pentanol, connects volatile natural-product chemistry with secretion, receptor, and metabolism research. This evidence-led guide shows how to translate docking, tissue-resolved metabolomics, and historical physiology findings into better assay decisions.

8395 records 1/560 page Next 12345 下5页 Last page